20181227 Evidence-Based Oncology for 2018

Breakthroughs in cancer therapy are demanding new ways to pay for care. While terms like value-based contracting have been around for several years, there’s more interest than ever as gene-based therapies hit the market. Here are the top stories for 2018 from our journal at the intersection of cancer care and reimbursement, Evidence-Based Oncology™ (EBO):

View Article